4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001140361-17-014883
Options or other derivatives
- President & CEO acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murray Mark J. President & CEO | 2017-03-24 | Grant or award · Employee Stock Option (Right to Buy) | +450,000 | 450,000 | D: show line 1 in the form |
Loading xslF345X03/doc1.xml…